VP
Insider
Versant Ventures VII GP, L.P.
10% ownerVersant Ventures VII GP, L.P. (10% owner) filed 1 Form 4 report as a reporting entity in the past 24 months (0 purchases, 1 sale), most often in LENZ Therapeutics, Inc. (LENZ). Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
–
no filings in the window
Last traded
Aug 26 2025
Filed Aug 26 2025
Median ADV $2.6M across their filed names
Open performance→Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
LENZ
LENZ Therapeutics, Inc.
LENZ · 0 buys · 1 sell
1 filing
Recent filings
LENZSALE
LENZ Therapeutics, Inc.
View filing →
–183,180 sh across 9 lots · price not plausible
Exec Aug 22 2025
Filed Aug 26 2025 · 5:30 PM ET